相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nutrient-dependent regulation of autophagy through the target of rapamycin pathway
Yu-Yun Chang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Inhibition of Autophagy Induction Delays Neuronal Cell Loss Caused by Dysfunctional ESCRT-III in Frontotemporal Dementia
Jin-A Lee et al.
JOURNAL OF NEUROSCIENCE (2009)
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2009)
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Luke S. Tain et al.
NATURE NEUROSCIENCE (2009)
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2009)
Role of Synucleins in Alzheimer's Disease
Leslie Crews et al.
NEUROTOXICITY RESEARCH (2009)
Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy
Maria Xilouri et al.
PLOS ONE (2009)
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Valerie Cullen et al.
MOLECULAR BRAIN (2009)
Cathepsin D is the main lysosomal enzyme involved in the degradation of α-synuclein and generation of its carboxy-terminally truncated species
Daniel Sevlever et al.
BIOCHEMISTRY (2008)
Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer's disease
Barry Boland et al.
JOURNAL OF NEUROSCIENCE (2008)
Organization of the pre-autophagosomal structure responsible for autophagosome formation
Tomoko Kawamata et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Small molecule enhancers of autophagy for neurodegenerative diseases
Sovan Sarkar et al.
MOLECULAR BIOSYSTEMS (2008)
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
Tianhong Pan et al.
NEUROBIOLOGY OF DISEASE (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa et al.
NEUROLOGY (2007)
Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death
Jian-hui Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Cortical Lewy body disease and Parkinson's disease dementia
David J. Burn
CURRENT OPINION IN NEUROLOGY (2006)
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
N. Parkinson et al.
NEUROLOGY (2006)
Interaction between Aβ peptide and α synuclein:: Molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease
Pravat K. Mandal et al.
NEUROCHEMICAL RESEARCH (2006)
Alzheimer disease with amygdala Lewy bodies:: A distinct form of α-synucleinopathy
Hirotake Uchikado et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Masaaki Komatsu et al.
NATURE (2006)
Autophagic stress in neuronal injury and disease
Charleen T. Chu
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer's disease
CC Janvin et al.
MOVEMENT DISORDERS (2006)
Design and cloning of lentiviral vectors expressing small interfering RNAs
Gustavo Tiscornia et al.
NATURE PROTOCOLS (2006)
Aggregate-prone proteins are cleared from the cytosol by autophagy: Therapeutic implications
Andrea Williams et al.
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 76 (2006)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
Ian G. McKeith
JOURNAL OF ALZHEIMERS DISEASE (2006)
Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
G Skibinski et al.
NATURE GENETICS (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Lysosomal pathology associated with α-synuclein accumulation in transgenic models using an eGFP fusion protein
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
α-Synuclein-positive structures induced in leupeptin-infused rats
T Nakajima et al.
BRAIN RESEARCH (2005)
Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study
RA Nixon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Aberrant phosphorylation of α-synuclein in human Niemann-Pick type C1 disease
Y Saito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?
D Aarsland et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Involvement of macroautophagy in the dissolution of neuronal inclusions
HJ Rideout et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Death by design: apoptosis, necrosis and autophagy
AL Edinger et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration
DM Walsh et al.
PROTEIN AND PEPTIDE LETTERS (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Aβ1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
E Masliah et al.
NEUROLOGY (2003)
α-synuclein is degraded by both autophagy and the proteasome
JL Webb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
α-Synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells:: role in the pathogenesis of Parkinson's disease
M Hashimoto et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis - An approach for slowing Alzheimer disease?
J Bendiske et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Gaucher disease associated with Parkinsonism:: Four further case reports
J Várkonyi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases
M Hashimoto et al.
NEUROMOLECULAR MEDICINE (2003)
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
GE Meredith et al.
BRAIN RESEARCH (2002)
The neuropathogenic contributions of lysosomal dysfunction
BA Bahr et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3β pathway -: Implications for neuroprotection
M Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
B Ravikumar et al.
HUMAN MOLECULAR GENETICS (2002)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease
E Rockenstein et al.
BRAIN RESEARCH (2001)
Gaucher disease and parkinsonism: A phenotypic and genotypic characterization
N Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2001)
α-Synuclein and the Lewy body disorders
DW Dickson
CURRENT OPINION IN NEUROLOGY (2001)
Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E
I Veinbergs et al.
EXPERIMENTAL NEUROLOGY (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Subcellular localization of angiotensin II in kidney and adrenal
JP van Kats et al.
JOURNAL OF HYPERTENSION (2001)
Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult
M Lee et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Cell biology - Autophagy as a regulated pathway of cellular degradation
DJ Klionsky et al.
SCIENCE (2000)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Spectrum of Parkinson's disease, Parkinson's dementia, and lewy body dementia
IG McKeith et al.
NEUROLOGIC CLINICS (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
分享论文
